Hitesh Kumar Dewangan

Dr. Hitesh Kumar Dewangan

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
ASAlok Nath Sharma
Alok Nath Sharma
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
PUPrabhat Kumar Upadhyay
Prabhat Kumar Upadhyay

18 August 2022 in Journal of Microencapsulation
Verified
Journal Article
Closed access
ASAlok Nath Sharma
Alok Nath Sharma
PUPrabhat Kumar Upadhyay
Prabhat Kumar Upadhyay
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
The study was to extend systemic circulation and biological half-life (t1/2) of trans-resveratrol (RSV) using solid lipid nanoparticles (RSV-SLN) to improve its anti-cancer potential.RSV-SLN was pr...

2 January 2022 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
RYRakesh Kumar Yadav
Rakesh Kumar Yadav
KSKamal Shah
Kamal Shah
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
Migraine is a frequent neurological condition characterised by throbbing headaches, nausea, photophobia, and phonophobia, among other symptoms. Sumatriptan belongs to a BCS class III, which exhibits poor oral bioavailability and several side effect. The objective of the present study was to develop solid lipid nanoparticles (SLNPs) of sumatriptan succinate for brain targeting by nasal route. Solvent injection method was used to increase the entrapment efficiency of hydrophilic drug. Thus, formulation was optimized by central composite design so as to minimum the particles size, optimized zeta potential and maximum entrapment efficiency, which found that 133.4 nm, -17.7 mV and 75.5% respectively. Optimized batch was further evaluated for surface morphology, FTIR spectroscopy, in vitro release, permeation across nasal mucosa and histopathology. Resulted that most of the particles are spherical in shape confirmed by SEM and TEM. The release of drug through the lipid was showed initial burst release followed by sustained release up to 12 h. The ex vivo diffusion study using goat nasal mucosa at pH 6.8 revealed that SLNPs permeation across nasal mucosa was quick, which sufficient for brain targeting. Histopathology studies further revealed integrity of nasal mucosa after treatment with SLNPs. The investigation indicated that hydrophilic drug, sumatriptan succinate can be successfully entrapped in SLNPs to target brain via nasal delivery, and thus it could be an effective approach for nose to brain delivery.

1 December 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ARAkriti Rai
Akriti Rai
KSKamal Shah
Kamal Shah
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
Contemporary medical research increasingly focuses on the blood-brain barrier (BBB) to maintain homeostasis in healthy individuals and provide solutions for neurological disorders, including brain cancer. Specialized in vitro modules replicate the BBB's complex structure and signalling using micro-engineered perfusion devices and advanced 3D cell cultures, thus advancing the understanding of neuropharmacology. This research explores nanoparticle-based biomolecular engineering for precise control, targeting, and transport of theranostic payloads across the BBB using nanorobots. The review summarizes case studies on delivering therapeutics for brain tumors and neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis. It also examines the advantages and disadvantages of nano-robotics. In conclusion, integrating machine learning and AI with robotics aims to develop safe nanorobots capable of interacting with the BBB without adverse effects. This comprehensive review is valuable for extensive analysis and is of great significance to healthcare professionals, engineers specializing in robotics, chemists, and bioengineers involved in pharmaceutical development and neurological research, emphasizing transdisciplinary approaches.

16 May 2022 in Journal of Microencapsulation
Verified
Journal Article
Closed access
LALakshmi
Lakshmi
SSSanjay Singh
Sanjay Singh
KSKamal Shah
Kamal Shah
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
LMLakshmi Maurya
Lakshmi Maurya
The current study focused on the development and evaluation of aqueous core nanocapsules (ACNs) as an effective carrier to deliver an optimal synergistic combination of a highly water soluble Vinor...

1 December 2021 in Current Nanomedicine
Verified
Journal Article
Closed access
PDF file
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
: Poor solubility of some medicinal compounds is a serious challenge that can be addressed by using a nano-suspension for improved delivery. The nanoparticles enhance the bioavailability along with the aqueous solubility of the drug, which is accomplished by increasing the active surface area of the drug. The gained attention of the nanosuspension is due to its stabilization facility, which is achieved by polymers, such as polyethylene glycol (PEG), having a particular size range of 10 - 100 nm. Hence, these nanoparticles have the capacity of binding to the targeted with very low damage to the healthy tissues. These are prepared by various methods, such as milling, high-pressure homogenization, and emulsification, along with melt emulsification. Moreover, surface modification and solidification have been used to add specific properties to the advanced therapies as post-processing techniques. For many decades, it has been known that water solubility hampers the bioavailability and not all drugs are water-soluble. In order to combat this obstacle, nanotechnology has been found to be of specific interest. For elevating the bioavailability by increasing the dissolution rate, the methodology of reduction of the associated drug particles into their subsequent submicron range is incorporated. For oral and non-oral administration, these nanosuspension formulations are used for the delivery of drugs.